<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31321663</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2020</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-1904</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology</Title><ISOAbbreviation>J Neuroimmune Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>688</StartPage><EndPage>696</EndPage><MedlinePgn>688-696</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11481-019-09866-x</ELocationID><Abstract><AbstractText>Oxidant toxicity has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS), an insidiously progressive neurodegenerative disorder involving upper and lower motor neurons. Here, we investigated the cellular and molecular mechanisms underlying the neuroprotective effects of an anti-oxidant genistein in SOD1-G93A transgenic mouse model of ALS. Rotarod test, hanging wire test and hindlimb clasping test were used to determined disease onset and assess motor performance. Immunostaining together with neuronal size measurement were used to count viable motor neurons. In addition, immunostaining procedure and ELISA kit were used to assess the inflammatory response in the spinal cord. Our results showed that Genistein administration suppressed the production of pro-inflammatory cytokines and alleviated gliosis in the spinal cord of SOD1-G93A mice. In addition, genistein administration induced autophagic processes and enhanced the viability of spinal motor neurons. As a result, genistein alleviated ALS-related symptoms and slightly prolonged the lifespan of SOD1-G93A mice. Taken together, our results indicate that genistein is neuroprotective in SOD1-G93A mice, suggesting genistein could be a promising treatment for human ALS. Graphical Abstract Genistein protects impariments in SOD1-G93A transgenic mouse model.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zichun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, 050000, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Jinsheng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, 050000, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shiping</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, 050000, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhenzhong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, 050000, Hebei, China. johndoctor1962@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>None</GrantID><Agency>Inter Funding Source</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neuroimmune Pharmacol</MedlineTA><NlmUniqueID>101256586</NlmUniqueID><ISSNLinking>1557-1890</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048789">Phytoestrogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>DH2M523P0H</RegistryNumber><NameOfSubstance UI="D019833">Genistein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C109415">SOD1 G93A protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019833" MajorTopicYN="N">Genistein</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048789" MajorTopicYN="N">Phytoestrogens</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Anti-oxidant</Keyword><Keyword MajorTopicYN="N">Genistein</Keyword><Keyword MajorTopicYN="N">Neuroprotection</Keyword><Keyword MajorTopicYN="N">SOD1-G93A mice</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31321663</ArticleId><ArticleId IdType="doi">10.1007/s11481-019-09866-x</ArticleId><ArticleId IdType="pii">10.1007/s11481-019-09866-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brain Res. 2016 Oct 15;1649(Pt B):189-200</Citation><ArticleIdList><ArticleId IdType="pubmed">27181519</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Neurosci. 2009 Jun;38(2):94-102</Citation><ArticleIdList><ArticleId IdType="pubmed">18712292</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Pathol. 2018 Jan;28(1):14-27</Citation><ArticleIdList><ArticleId IdType="pubmed">27880990</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Nerve. 2017 May;69(5):565-569</Citation><ArticleIdList><ArticleId IdType="pubmed">28479534</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Mol Neurosci. 2017 Aug 22;10:263</Citation><ArticleIdList><ArticleId IdType="pubmed">28878620</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Toxicol. 2015 Jun;89(6):867-82</Citation><ArticleIdList><ArticleId IdType="pubmed">25690731</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2014 Jan;17(1):17-23</Citation><ArticleIdList><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Histol Histopathol. 2017 Nov;32(11):1115-1123</Citation><ArticleIdList><ArticleId IdType="pubmed">28397197</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Neurophysiol. 2011 Aug;122(8):1660-70</Citation><ArticleIdList><ArticleId IdType="pubmed">21354365</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Rev Oncol Hematol. 2017 Nov;119:13-22</Citation><ArticleIdList><ArticleId IdType="pubmed">29065980</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Pharmacother. 2016 Aug;82:379-92</Citation><ArticleIdList><ArticleId IdType="pubmed">27470376</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Neurol Sci. 2017 Jan;44(1):90-95</Citation><ArticleIdList><ArticleId IdType="pubmed">27774920</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropharmacology. 2013 Mar;66:253-63</Citation><ArticleIdList><ArticleId IdType="pubmed">22634363</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Ther. 2003 Jun;98(3):379-414</Citation><ArticleIdList><ArticleId IdType="pubmed">12782245</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuron. 2014 Mar 5;81(5):1009-1023</Citation><ArticleIdList><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurol Res. 2017 Jan;39(1):73-82</Citation><ArticleIdList><ArticleId IdType="pubmed">27809706</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Biol Sci. 2017 Apr 10;13(5):574-587</Citation><ArticleIdList><ArticleId IdType="pubmed">28539831</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurosci Lett. 2017 Jan 1;636:3-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27150074</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurol Neurosurg Psychiatry. 2014 May;85(5):478-85</Citation><ArticleIdList><ArticleId IdType="pubmed">23833266</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurobiol Dis. 2004 Apr;15(3):461-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15056453</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1994 Dec 22;331(25):1721-2</Citation><ArticleIdList><ArticleId IdType="pubmed">7832899</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2015 Mar 27;347(6229):1436-41</Citation><ArticleIdList><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacol Res. 2018 Mar;129:100-114</Citation><ArticleIdList><ArticleId IdType="pubmed">29183770</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 1999 May 19;258(3):685-8</Citation><ArticleIdList><ArticleId IdType="pubmed">10329446</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Aging Neurosci. 2017 Jul 25;9:242</Citation><ArticleIdList><ArticleId IdType="pubmed">28790913</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2017 Nov 2;171(4):725</Citation><ArticleIdList><ArticleId IdType="pubmed">29100067</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Brain. 2017 Feb 2;10(1):5</Citation><ArticleIdList><ArticleId IdType="pubmed">28148298</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1993 Jul 22;364(6435):362</Citation><ArticleIdList><ArticleId IdType="pubmed">8332197</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomed Pharmacother. 2015 Dec;76:30-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26653547</ArticleId></ArticleIdList></Reference><Reference><Citation>Phytomedicine. 2018 Apr 1;43:11-20</Citation><ArticleIdList><ArticleId IdType="pubmed">29747742</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Neurobiol. 2019 Mar;56(3):2137-2158</Citation><ArticleIdList><ArticleId IdType="pubmed">29995256</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>